A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Urothelial Carcinoma
Related studies linked through entity extraction aliases.
QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence
- Status
- UNKNOWN
- Phase
- PHASE2
Radium-223 and Atezolizumab in Patients With Urothelial Carcinoma With Bone Metastases Who Have Had Disease Progression After Platinum-Based Chemotherapy
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Atezolizumab + Guadecitabine in Patients With Checkpoint Inhibitor Refractory or Resistant Urothelial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy
- Status
- COMPLETED
- Phase
- PHASE1
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Two Dosing Schedules of Atezolizumab in Combination With Gemcitabine and Cisplatin as First-Line Treatment for Metastatic Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study Evaluating MM-310 in Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence
- Status
- UNKNOWN
- Phase
- PHASE2
Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
A Study of MOXR0916 in Combination With Atezolizumab Versus Atezolizumab Alone in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma Who Are Ineligible for Cisplatin-Based Therapy
- Status
- TERMINATED
- Phase
- PHASE2
CLE Characteristics of Upper Urinary Tract Urothelial Carcinoma
- Status
- COMPLETED
- Phase
- N/A
Confocal Laser Endomicroscopy in the Lower Urinary Tract
- Status
- COMPLETED
- Phase
- N/A
Development of Diagnostics and Treatment of Urological Cancers
- Status
- RECRUITING
- Phase
- NA
A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers
- Status
- COMPLETED
- Phase
- PHASE1